John Segreti to Fluoroquinolones
This is a "connection" page, showing publications John Segreti has written about Fluoroquinolones.
Connection Strength
0.937
-
Impact of a fluoroquinolone formulary change on acquisition of quinolone-resistant gram-negative bacilli. Eur J Clin Microbiol Infect Dis. 2005 Jun; 24(6):405-10.
Score: 0.267
-
Fluoroquinolones for the treatment of nongonococcal urethritis/cervicitis. Am J Med. 1991 Dec 30; 91(6A):150S-152S.
Score: 0.105
-
In vitro activity of temafloxacin against pathogens causing sexually transmitted diseases. Am J Med. 1991 Dec 30; 91(6A):24S-26S.
Score: 0.105
-
Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones. J Ocul Pharmacol Ther. 2012 Feb; 28(1):3-11.
Score: 0.104
-
In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens. Antimicrob Agents Chemother. 1990 Jun; 34(6):971-3.
Score: 0.094
-
In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea. Antimicrob Agents Chemother. 1989 Aug; 33(8):1385-7.
Score: 0.089
-
In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains. Diagn Microbiol Infect Dis. 1989 May-Jun; 12(3 Suppl):87S-88S.
Score: 0.087
-
In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis. Antimicrob Agents Chemother. 1989 Jan; 33(1):118-9.
Score: 0.086